Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 615

2.

Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.

Foster CS, Chang PY, Ahmed AR.

Ophthalmology. 2010 May;117(5):861-9. doi: 10.1016/j.ophtha.2009.09.049. Epub 2010 Jan 4.

PMID:
20045562
3.

Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.

Sami N, Letko E, Androudi S, Daoud Y, Foster CS, Ahmed AR.

Ophthalmology. 2004 Jul;111(7):1380-2.

PMID:
15234140
4.

Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.

Thorne JE, Woreta FA, Jabs DA, Anhalt GJ.

Ophthalmology. 2008 Dec;115(12):2146-2152.e1. doi: 10.1016/j.ophtha.2008.08.002. Epub 2008 Oct 18.

PMID:
18930554
6.

The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.

Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS.

Ophthalmology. 2002 Jan;109(1):111-8.

PMID:
11772589
9.

Ocular cicatricial pemphigoid, keratomycosis, and intravenous immunoglobulin therapy.

Iaccheri B, Roque M, Fiore T, Papadaki T, Mathew B, Baltatzis S, Emara B, Tokarewicz AC, Foster CS.

Cornea. 2004 Nov;23(8):819-22.

PMID:
15502484
10.

Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid.

Sami N, Bhol KC, Razzaque Ahmed A.

Clin Immunol. 2002 Jan;102(1):59-67.

PMID:
11781068
11.

Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.

Foster CS, Ahmed AR.

Ophthalmology. 1999 Nov;106(11):2136-43.

PMID:
10571350
12.
13.

Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid.

Donnenfeld ED, Perry HD, Wallerstein A, Caronia RM, Kanellopoulos AJ, Sforza PD, D'Aversa G.

Ophthalmology. 1999 Jan;106(1):72-8; discussion 79.

PMID:
9917784
14.

Evaluation of mucous membrane pemphigoid with ocular involvement in young patients.

Rauz S, Maddison PG, Dart JK.

Ophthalmology. 2005 Jul;112(7):1268-74.

PMID:
15921743
15.

[Cicatricial pemphigoid: management in stomatology].

Agbo-Godeau S, de Lima Soares P, Szpirglas H.

Rev Stomatol Chir Maxillofac. 2004 Sep;105(4):206-10. French.

PMID:
15510070
16.

[Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid].

Celis Sánchez J, López Ferrando N, García Largacha M, González del Valle F, Ortiz de la Torre MJ.

Arch Soc Esp Oftalmol. 2002 Sep;77(9):501-6. Spanish.

PMID:
12221542
17.

Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid.

Bhol K, Mohimen A, Neumann R, Yunis J, Foster S, Yunis EJ, Ahmed AR.

Curr Eye Res. 1996 May;15(5):521-32.

PMID:
8670753
18.

[Diagnostics and pharmacological treatment of ocular cicatrical pemphigoid].

Brydak-Godowska J, Moneta-Wielgoś J, Pauk-Domańska M, Dróbecka-Brydak E, Samsel A, Kecik M, Kowalewski C, Mackiewicz W, Kecik D.

Klin Oczna. 2005;107(10-12):725-7. Review. Polish.

PMID:
16619831
19.

Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid.

El Darouti MA, Fakhry Khattab MA, Hegazy RA, Hafez DA, Gawdat HI.

Eur J Ophthalmol. 2011 Sep-Oct;21(5):529-37. doi: 10.5301/EJO.2011.6294.

PMID:
21279976
20.

Methotrexate therapy for ocular cicatricial pemphigoid.

McCluskey P, Chang JH, Singh R, Wakefield D.

Ophthalmology. 2004 Apr;111(4):796-801.

PMID:
15051215

Supplemental Content

Support Center